Lipophilic Statins and Risk of Hepatocellular Carcinoma and Mortality: A Prospective, Nationwide Population with Chronic Viral Hepatitis

被引：0
|
作者：
Simon, Tracey G. [1 ]
Duberg, Ann-Sofi [2 ]
Aleman, Soo [3 ]
Hagstrom, Hannes [4 ]
Chung, Raymond T. [5 ,6 ,7 ]
Ludvigsson, Jonas F. [8 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Orebro Univ Hosp, Orebro, Sweden
[3] Karolinska Univ Hosp, Dept Infect Dis, Solna, Sweden
[4] Karolinska Inst, Div Hepatol, Ctr Digest Dis, Solna, Sweden
[5] Massachusetts Gen Hosp, Ctr Liver, Boston, MA 02114 USA
[6] Massachusetts Gen Hosp, Gastrointestinal Div, Boston, MA 02114 USA
[7] Harvard Med Sch, Boston, MA USA
[8] Karolinska Inst, Med Epidemiol & Biostat, Solna, Sweden
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
93
引用
收藏
页码：59A / 60A
页数：2
相关论文
共 50 条
  • [1] Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
    Simon, Tracey G.
    Duberg, Ann-Sofi
    Aleman, Soo
    Hagstrom, Hannes
    Nguyen, Long H.
    Khalili, Hamed
    Chung, Raymond T.
    Ludvigsson, Jonas F.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (05) : 318 - +
  • [2] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC VIRAL HEPATITIS
    Kane, Lara J.
    Macdonald, Graeme A.
    CANCER FORUM, 2009, 33 (02)
  • [3] Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (01) : 97 - 107
  • [4] ASPIRIN USE IS ASSOCIATED WITH REDUCED RISK FOR INCIDENT HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC VIRAL HEPATITIS: RESULTS FROM A NATIONWIDE POPULATION
    Simon, Tracey G.
    Duberg, Ann-Sofi
    Aleman, Soo
    Chung, Raymond T.
    Ludvigsson, Jonas F.
    GASTROENTEROLOGY, 2019, 156 (06) : S1200 - S1200
  • [5] Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection
    Lui, Grace Chung-Yan
    Hui, Vicki Wing-Ki
    Sze, Shun-Fung
    Wong, Bonnie Chun-Kwan
    Cheung, Catherine
    Lee, Man-Po
    Yip, Terry Cheuk-Fung
    Tse, Yee-Kit
    Lai, Jimmy Che-To
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Hui, Yee-Tak
    Wong, Grace Lai-Hung
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (08) : 814 - 823
  • [6] Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Zhang, Xuehong
    Ahn, Sang Hoon
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (08) : 1448 - 1458
  • [7] Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
    Abdurakhmanov, D. T.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (10) : 94 - 97
  • [8] Chronic Viral Hepatitis and Hepatocellular Carcinoma
    Yagil Barazani
    Jonathan R. Hiatt
    Myron J. Tong
    Ronald W. Busuttil
    World Journal of Surgery, 2007, 31 : 1245 - 1250
  • [9] Chronic viral hepatitis and hepatocellular carcinoma
    Barazani, Yagil
    Hiatt, Jonathan R.
    Tong, Myron J.
    Busuttil, Ronald W.
    WORLD JOURNAL OF SURGERY, 2007, 31 (06) : 1243 - 1248
  • [10] Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients"
    Zhao, Gang
    Shi, Xiaobao
    Zhang, Lingyun
    Liang, Hongyuan
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1324 - 1325
12345